Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: J Addict Med. 2021 Jan-Feb;15(1):10–12. doi: 10.1097/ADM.0000000000000674

Language matters: It’s time we change how we talk about addiction and its treatment

Aleksandra E Zgierska 1, Michael M Miller 2,3,4,5, David P Rabago 6, Florence Hilliard 7,8, Patty McCarthy 9, Penney Cowan 10, Edwin A Salsitz 11
PMCID: PMC7704939  NIHMSID: NIHMS1627485  PMID: 32482954

The Editorial1 by Drs. Saitz, Miller, Fiellin and Rosenthal, “Recommended Use of Terminology in Addiction Medicine,” emphasizes the importance of medically-accurate, non-stigmatizing terminology to be used by health care professionals when referring to addiction-related diagnoses and management. As individuals who represent clinicians, individuals with a lived experience, and patient advocates, we are in full support of the non-stigmatizing terminology proposed in the Editorial. We appreciate the opportunity to expand the discussion about addiction-related language and to provide descriptions and recommendations for the use of non-stigmatizing “person-first” language.2,3

The way we communicate about addiction, its treatment, and treatment outcomes matters to individuals affected by addiction, their families, and communities.4 Non-stigmatizing, non-judgmental, medically-based language in public discourse, community-level conversations and clinical encounters surrounding addiction can facilitate improved patient access to and engagement with care.2 The converse is also true; stigmatizing language, regardless of intent, can perpetuate stigma, including “self-stigma” (internalization of stigma),5 with feelings of shame, inferiority and fault (“It’s all my fault.” “I’m a bad person.”), and deter people from disclosing and discussing addiction and receiving treatment.68 “Courtesy stigma” can extend stigma and its negative consequences by association to family members and loved ones, and even impact clinician and public health level responses, contributing to health and care delivery disparities in addiction.812

Treatment for addiction is effective but only if the affected individual receives it. Pharmacotherapy for addiction involving opioid use reduces mortality by 50%; yet only a minority of people with opioid addiction receive it.13 This dramatic gap between efficacy and receipt of pharmacotherapy cannot be solely explained by inadequate treatment capacity. Although access to pharmacotherapy for opioid use disorder is suboptimal, even when medications are available, patients may be hesitant and even decline to start or continue them due to addiction treatment-related stigma and numerous misconceptions (“It’s replacing one addiction with another.”) and vilification (“You are not in recovery until you’re off these drugs.”) of these life-saving treatment options.14

The ongoing opioid crisis has also brought stigmatization to the opioid-based management of pain.15 Individuals treated with appropriately prescribed long-term opioids for chronic non-cancer pain often experience stigma, discrimination and even hostility from healthcare professionals, exacerbating patient suffering. Physical dependence and withdrawal, expected in those treated with long-term daily opioids, make the diagnosis of opioid use disorder challenging because these phenomena are also two of the diagnostic criteria for the diagnosis of substance use disorder.

Because language can help or harm, the intentional use of appropriate language in addiction-related communication is essential. We propose general principles and provide examples of intentional person-centered terminology, which we believe would improve treatment and its outcomes, if generally adopted. First, we suggest shifting away from language that defines a person through the lens of disease or through the lens of being a patient. Much as medical students are encouraged early in training to say “The person with appendicitis in Room 12” rather than “The appendicitis in Room 12,” addiction-related care would refer to “a person with addiction” or “a person with opioid-treated chronic pain” rather than “addict,” “addicted patient” or “opioid-treated chronic pain patient.” Such person-first language implicitly acknowledges that a patient’s life extends beyond a given disease,2,3 and makes clear that having addiction does not change the reality that the afflicted individual is a person. While such linguistic changes are subtle, they communicate that addiction or chronic pain are only one aspect of a person’s health and quality of life, decrease stigma and encourage healing relationships.

Second, it is particularly important for health care professionals to use professional terms and avoid colloquial, imprecise, or stigmatizing terms. For example, when discussing the management and monitoring of the disease and treatment progress (e.g., remission), the terminology needs to be professional and clear, without the use of vocabulary that may suggest judgement on the person’s character (“Your urine was dirty”). In addition, we must improve our portrayal of addiction treatment, especially medications for opioid addiction and overdose prevention, to avoid stigmatization of individuals who receive or consider such treatment. For example, referring to maintenance treatment of opioid use disorder (OUD) with buprenorphine or methadone as “replacement therapy” or “replacing one addiction for another” is not evidence-based and disparages long-term therapy. We also suggest that prescribed and medically-authorized pharmacotherapies be called “medications” rather than “drugs” to reduce the implicit associations between prescribed, monitored treatments (e.g., methadone, buprenorphine and naltrexone for OUD) and misuse of non-prescribed (i.e., illicitly-obtained) substances.

Although non-professional terminology may be used by individuals with addiction, the role of clinicians, educators, researchers, policymakers, and community and cultural leaders is to actively work toward destigmatization of addiction and its treatment, in part through the use of non-stigmatizing language. Role-modeling better approaches can help us move away from the inaccurate, outdated view of addiction as a character flaw or moral failing deserving of punishment, toward that of a treatable chronic disease requiring long-term treatment. Drawing upon our collective clinical, research, advocacy and personal experiences, and the published literature, we developed a list that expands the Editorial’s terminology,1 and includes commonly used stigmatizing terms and their recommended replacements. This list is meant to offer a practical cross-walk between the stigmatizing terms to be avoided and more recommended diction to facilitate the dialogue about addiction in a more intentional, therapeutic manner. This linguistic cross-walk can be applied toward future conversations among stakeholders or to conduct a “language audit” of existing materials for terms that may be stigmatizing and should be replaced with more person-first language. It should not be viewed as exhaustive or “final” though – language is dynamic, and the meaning of specific terms will change with the changing cultural and scientific landscapes.

Table.

Proposed person-first terminology to reduce stigmatization of and improve clarity of communication related to addiction and its treatment.

Stigmatizing language Proposed terminology Comments
Abuser; addict; street addict; former or reformed addict; alcoholic, boozer; crackhead, cokehead; pothead, weed user; dope addict; narco; junkie; druggy; tweaker; dope fiend; alkie; lush Person with [substance] use or [substance use or behavior] disorder or addiction involving [substance use or behavior]. Person in remission from a [substance use or behavior] disorder. Person with [substance use or behavior] disorder who is homeless. Some of these terms can refer to a person with or without an substance use or behavior disorder. A disorder is diagnosed if the DSM-5 criteria for use or behavior disorder are met. See Editorial for guidance on the diagnosis-related terminology.1
Having a drug habit or bad habit; having a drug of choice, drug of abuse Having a [substance use or behavior] disorder or addiction involving [substance use or behavior]. Addiction is a chronic disease, not a habit; the term ‘habit’ or ‘choice’ implies that it is merely a problematic behavior and something that a person can ‘fix’ by simply desiring a change. “Cigarette habit” and “heroin habit” are examples of such problematic terms.
Smoker Person with cannabis and/or tobacco or nicotine use disorder, or addiction involving cannabis / tobacco / nicotine use. With the increasing use of vaping and e-cigarettes, it is suggested to use the term ‘nicotine’ rather than ‘tobacco’ as it encompasses both tobacco chewing and smoking, and the use of non-combustible nicotine delivery systems.
Addicted baby; crack baby; meth baby Neonate (or newborn, child) with [substance] withdrawal; or with neonatal withdrawal syndrome; or with in utero exposure to [named substance] Children can be exposed in utero to substances. They can develop a physical or physiological dependence with prolonged in utero exposure to certain substances that can lead to a withdrawal syndrome post-birth. They are not born with addiction -- they do not meet the diagnostic criteria for SUD.
Being clean or sober Being substance-free. Being abstinent. Being in remission. Toxicology test testing “negative” for a [substance]. Remission occurs when the symptoms of a disease subside. Recovery extends beyond the remission phase. See Editorial for guidance on the remission related terminology.1
Being dirty Using [substances]. Toxicology test testing “positive” for a [substance]. “Dirty urine” implies that the person is a “dirty” person.
Getting/being high; stoned; wasted Being intoxicated; being under the influence of [substance]
Shooting up, jacking up, slamming, banging, pinning intravenous drug use; injection drug use Intravenous drug use refers to substance use and does not automatically mean that the individual has addiction.
Kicking the habit Initiate abstinence; receive/ start treatment; enter remission, etc. The commonly used phrase ‘kick the habit’ implies that it is a habit not a disease, and that the ‘treatment’ occurs simply based on sufficient ‘willpower’ to stop the behaviors.
Being in detox Undergoing a detoxification treatment; withdrawal management/treatment; tapering off medications
Being in rehab Undergoing intensive addiction treatment or management; intensive pain rehabilitation or restoration program
Replacement or substitution treatment for OUD; Medication-Assisted Treatment (MAT) Medication treatment; pharmacotherapy Misconceptions about agonist medications, buprenorphine and methadone (such as “they replace one addiction for another”), imply that this evidence-based treatment for OUD is a continuation of drug use; statements that people treated with agonist medications are not in remission because they are not “drug free” convey a similar message. Using the term Medication-Assisted Treatment can imply that medication per se is not a treatment.1 Because the acronym MAT has now deep cultural roots, the change to “Medications for Addiction Treatment” could preserve the commonly-used acronym while changing its full name to a non-stigmatizing one.
Having dirty / clean urine Toxicology test testing positive / negative for a [substance]. Results are unexpected / expected; inconsistent / consistent with the prescribing record.
Recidivism Remission See Editorial for guidance on the remission-related terminology.1

Contributor Information

Aleksandra E. Zgierska, Pennsylvania State University, College of Medicine, Department of Family and Community Medicine.

Michael M. Miller, University of Wisconsin-Madison, School of Medicine and Public Health, Department of Psychiatry; Past President, American Society of Addiction Medicine; Past Director, American Board of Addiction Medicine; Past Director, American College of Academic Addiction Medicine.

David P. Rabago, Pennsylvania State University, College of Medicine, Department of Family and Community Medicine.

Florence Hilliard, Wisconsin Voices for Recovery; University of Wisconsin-Madison, School of Medicine and Public Health, Department of Family Medicine and Community Health.

Patty McCarthy, Faces & Voices of Recovery.

Penney Cowan, American Chronic Pain Association.

Edwin A. Salsitz, Mount Sinai Beth Israel, Icahn School of Medicine.

References

  • 1.Saitz R, Miller SC, Fiellin DA, Rosenthal RN. Recommended Use of Terminology in Addiction Medicine. J Addict Med. 2020. May 29. doi: 10.1097/ADM.0000000000000673, Online ahead of print. [DOI] [PubMed] [Google Scholar]
  • 2.Botticelli MP. Memorandum to Heads of Executive Departments and Agencies: Changing Federal Terminology Regarding Substance Use and Substance Use Disorders. Executive Office of the President, Office of National Drug Control Policy; Washington, D.C., January 9, 2017. Retrieved on Feb 22, 2020 from: https://www.whitehouse.gov/sites/whitehouse.gov/files/images/Memo%20-%20Changing%20Federal%20Terminology%20Regrading%20Substance%20Use%20and%20Substance%20Use%20Disorders.pdf [Google Scholar]
  • 3.National Institute on Drug Abuse. Words Matter - Terms to Use and Avoid When Talking About Addiction. National Institutes of Health National Institute on Drug Abuse, January 2020. Retrieved on Feb 22, 2020 from: https://www.drugabuse.gov/nidamed-medical-health-professionals/health-professions-education/words-matter-terms-to-use-avoid-when-talking-about-addiction [Google Scholar]
  • 4.Kelly JF, Richard Saitz R, Wakeman S. Language, Substance Use Disorders, and Policy: The Need to Reach Consensus on an “Addiction-ary.” ALCOHOLISM TREATMENT QUARTERLY, 2016, 34(1):116–123. 10.1080/07347324.2016.1113103 [DOI] [Google Scholar]
  • 5.Corrigan PW, Rao D. On the self-stigma of mental illness: stages, disclosure, and strategies for change. Can J Psychiatry 2012;57(8):464–469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Hammarlund R, Crapanzano KA, Luce L, Mulligan L, Ward KM. Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders. Subst Abuse Rehabil, 2018; 9: 115–136. doi: 10.2147/SAR.S183256 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Crapanzano KA, Hammarlund R, Ahmad B, Hunsinger N, Kullar R. The association between perceived stigma and substance use disorder treatment outcomes: a review. Subst Abuse Rehabil. 2018. December 27;10:1–12. doi: 10.2147/SAR.S183252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Tsai AC, Kiang MV, Barnett ML, Beletsky L, Keyes KM, McGinty EE, Smith LR, Strathdee SA, Wakeman SE, Venkataramani AS. Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLoS Med. 2019. November 26;16(11):e1002969. doi: 10.1371/journal.pmed.1002969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Phillips R, Benoit C, Hallgrimsdottir H, Vallance K. Courtesy stigma: a hidden health concern among front‐line service providers to sex workers. Sociology of Health & Illness, 2012, 34(5): 681–696. 10.1111/j.1467-9566.2011.01410.x [DOI] [PubMed] [Google Scholar]
  • 10.van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1–2):23–35. [DOI] [PubMed] [Google Scholar]
  • 11.Hatzenbuehler ML, Phelan JC, Link BG. Stigma as a fundamental cause of population health inequalities. Am J Public Health. 2013. May;103(5):813–21. doi: 10.2105/AJPH.2012.301069 Epub 2013 Mar 14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Stangl AL, Earnshaw VA, Logie CH, van Brakel W, Simbayi LC, Barré I, Dovidio JF. The Health Stigma and Discrimination Framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Med 2019; 17: 31. doi: 10.1186/s12916-019-1271-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.The ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. American Society of Addiction Medicine, 2015. Retrieved on Feb 22, 2020 from: https://www.asam.org/docs/default-source/practice-support/guidelines-and-consensus-docs/asam-national-practice-guideline-supplement.pdf [DOI] [PMC free article] [PubMed]
  • 14.Corrigan PW, Nieweglowski K. Stigma and the public health agenda for the opioid crisis in America. Int J Drug Policy. 2018. September;59:44–49. doi: 10.1016/j.drugpo.2018.06.015 [DOI] [PubMed] [Google Scholar]
  • 15.McCradden MD, Vasileva D, Orchanian-Cheff A, Buchman DZ. Ambiguous identities of drugs and people: A scoping review of opioid-related stigma. Int J Drug Policy. 2019. December;74:205–215. doi: 10.1016/j.drugpo.2019.10.005. [DOI] [PubMed] [Google Scholar]

RESOURCES